相关实验视频

Updated: May 11, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

在经过皮肤冠状动脉干预的冠状动脉疾病患者中SYNTAX评分II的预后值 - 队列研究

Santhosh Satheesh¹, Ritesh Kumar², Ajith Ananthakrishna Pillai¹

¹Department of Cardiology, JIPMER, Puducherry, India.

Indian heart journal

|March 7, 2024

概括

SYNTAX评分II有效预测经皮冠状动脉干预 (PCI) 患者的住院和1年死亡率以及主要不良心脏事件 (MACE). 较高的分数表明风险增加,证实了其预后价值.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
临床风险分层的临床风险分层

背景情况:

关于SYNTAX评分II在接受皮肤冠状动脉干预 (PCI) 的患者的预后价值的数据有限.
本研究调查了SYNTAX评分II对PCI患者住院和1年死亡率的预测效用.

研究的目的:

评估SYNTAX评分II在预测死亡率和主要心脏不良事件 (MACE) 中的预后意义.
评估SYNTAX评分II对接受PCI的患者风险分层的有用性.

主要方法:

一项队列研究分析了2018年1月至2019年12月期间接受PCI的1000名患者.
根据SYNTAX评分II三位数 (<22,22-27.7,>27.7) 的数据,患者被分为三组.
医院住院和12个月死亡率和MACE在各组进行了分析.

主要成果:

整体12个月死亡率为6% (60名患者),MACE发生在9% (87名患者).
具有较高SYNTAX II评分的患者表现出显著更高的12个月死亡率 (P < 0.01) 和MACE (P < 0.01).
与较低的三位数相比,最高的三位数 (>27.7) 显示出增加的住院死亡率,全因死亡率,心血管死亡率,心肌梗塞,不稳定性胸痛,再血管化和MACE.

结论:

较高的SYNTAX评分II与增加的住院和12个月死亡率和PCI后的MACE有关.
该SYNTAX评分II显示出强大的预测能力,无论是在医院和12个月的心血管和所有原因的死亡率.
在接受PCI的患者中,SYNTAX评分II作为一种有价值的风险分层工具.

关键词:

冠状动脉疾病是一种冠状动脉疾病.通过皮肤进行冠状动脉干预.语法得分II 语法得分II 语法得分

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...